Mesenchymal Stromal Cell-Based Therapy—An Alternative to Arthroplasty for the Treatment of Osteoarthritis? A State of the Art Review of Clinical Trials

Osteoarthritis (OA) is the most common degenerative joint disorder worldwide and to date no regenerative treatment has been established in clinical practice. This review evaluates the current literature on the clinical translation of mesenchymal stromal cell (MSC)-based therapy in OA management with...

Descripción completa

Detalles Bibliográficos
Autores principales: Maleitzke, Tazio, Elazaly, Hisham, Festbaum, Christian, Eder, Christian, Karczewski, Daniel, Perka, Carsten, Duda, Georg N., Winkler, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409016/
https://www.ncbi.nlm.nih.gov/pubmed/32630066
http://dx.doi.org/10.3390/jcm9072062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409016/
https://www.ncbi.nlm.nih.gov/pubmed/32630066
http://dx.doi.org/10.3390/jcm9072062

Ejemplares similares